Found: 17
Select item for more details and to access through your institution.
Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy.
- Published in:
- Journal of Child Neurology, 2019, v. 34, n. 5, p. 284, doi. 10.1177/0883073819827407
- By:
- Publication type:
- Article
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
- Published in:
- Epilepsia (Series 4), 2016, v. 57, n. 2, p. 243, doi. 10.1111/epi.13279
- By:
- Publication type:
- Article
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel.
- Published in:
- Epilepsia (Series 4), 2015, v. 56, n. 8, p. 1252, doi. 10.1111/epi.13054
- By:
- Publication type:
- Article
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures.
- Published in:
- Epilepsia (Series 4), 2015, v. 56, n. 7, p. e90, doi. 10.1111/epi.13019
- By:
- Publication type:
- Article
Perampanel for adjunctive treatment of partial-onset seizures: A pooled dose-response analysis of phase III studies.
- Published in:
- Epilepsia (Series 4), 2014, v. 55, n. 3, p. 423, doi. 10.1111/epi.12527
- By:
- Publication type:
- Article
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 8, p. 1481, doi. 10.1111/epi.12212
- By:
- Publication type:
- Article
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 1, p. 117, doi. 10.1111/j.1528-1167.2012.03638.x
- By:
- Publication type:
- Article
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 1, p. 126, doi. 10.1111/j.1528-1167.2012.03648.x
- By:
- Publication type:
- Article
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK‐041 in healthy participants and patients with stable schizophrenia.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 8, p. 3872, doi. 10.1111/bcp.15305
- By:
- Publication type:
- Article
Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 2, p. 422, doi. 10.1111/bcp.12951
- By:
- Publication type:
- Article
Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation.
- Published in:
- Journal of Cellular Biochemistry, 1993, v. 51, n. 2, p. 206, doi. 10.1002/jcb.240510213
- By:
- Publication type:
- Article
Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies.
- Published in:
- Epilepsia (Series 4), 2020, v. 61, n. 7, p. 1491, doi. 10.1111/epi.16573
- By:
- Publication type:
- Article
Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures.
- Published in:
- Epilepsia (Series 4), 2020, v. 61, n. 1, p. 125, doi. 10.1111/epi.16413
- By:
- Publication type:
- Article
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open‐label extension of phase III randomized trials: Study 307.
- Published in:
- Epilepsia (Series 4), 2018, v. 59, n. 4, p. 866, doi. 10.1111/epi.14044
- By:
- Publication type:
- Article
Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studies.
- Published in:
- Epilepsia (Series 4), 2017, v. 58, n. 1, p. 51, doi. 10.1111/epi.13600
- By:
- Publication type:
- Article
Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety.
- Published in:
- Epilepsia (Series 4), 2016, v. 57, n. 7, p. 1120, doi. 10.1111/epi.13417
- By:
- Publication type:
- Article
Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double-Blind, Placebo-Controlled, Parallel-Group Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 1997, v. 37, n. 10, p. 640, doi. 10.1046/j.1526-4610.1997.3710640.x
- By:
- Publication type:
- Article